Get the Stockscreener App
2.44
4.50%
0.13
Kiora Pharmaceuticals Inc stock is traded at $2.44, with a volume of 84,157.
It is up +4.50% in the last 24 hours and down -12.22% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.31
Open:
$2.23
24h Volume:
84,157
Relative Volume:
1.54
Market Cap:
$8.41M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.17
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-4.59%
1M Performance:
-12.22%
6M Performance:
-27.18%
1Y Performance:
-32.95%
1-Day Range:
$2.23
$2.53
1-Week Range:
$2.22
$2.65
52-Week Range:
$2.21
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.45 | 7.93M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.29 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.61 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.65 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.27 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.17 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
News impact scoring models applied to Kiora Pharmaceuticals Inc.Take Profit & Fast Entry High Yield Tips - newser.com
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investors2025 Analyst Calls & AI Driven Price Predictions - newser.com
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsPrice Action & AI Driven Stock Movement Reports - newser.com
Is it time to cut losses on Kiora Pharmaceuticals Inc.Quarterly Market Review & Stepwise Trade Execution Plans - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendJuly 2025 Opening Moves & Consistent Profit Trade Alerts - newser.com
Chart based exit strategy for Kiora Pharmaceuticals Inc.2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Why global investors buy Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
How buyback programs support Kiora Pharmaceuticals Inc. (7EY) stockCPI Data & Stock Market Timing Techniques - newser.com
Will Kiora Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
When is the best time to exit Kiora Pharmaceuticals Inc.July 2025 Gainers & Consistent Growth Equity Picks - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.Bear Alert & AI Enhanced Trade Execution Alerts - newser.com
Can Kiora Pharmaceuticals Inc. rally from current levelsTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Real time breakdown of Kiora Pharmaceuticals Inc. stock performance2025 Dividend Review & Free Daily Entry Point Trade Alerts - newser.com
Can Kiora Pharmaceuticals Inc. stock double in next 5 yearsMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitors2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Can Kiora Pharmaceuticals Inc. (7EY) stock attract ESG investmentsSwing Trade & Stock Market Timing Techniques - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probability2025 Support & Resistance & Daily Risk Controlled Trade Plans - newser.com
Using data filters to optimize entry into Kiora Pharmaceuticals Inc.Earnings Trend Report & Trade Opportunity Analysis Reports - newser.com
Will Kiora Pharmaceuticals Inc. stock deliver consistent dividends2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
How to track smart money flows in Kiora Pharmaceuticals Inc.July 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
What analysts say about Kiora Pharmaceuticals Inc stockOptions Trading Strategies & Small Entry Investment Ideas - earlytimes.in
Kiora (NASDAQ: KPRX) joins RARE-X Vision Consortium to support rare ocular data sharing - Stock Titan
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema? - MSN
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):